Eli Lilly: "I would not buy the stock at this level. I would wait for a pullback." Dutch Bros: "I like the situation." ...
Eli Lilly & Co. closed $63.38 below its 52-week high ($972.53), which the company reached on August 22nd.
Led by Sen. Dick Durbin of Illinois, senators question if direct-to-consumer website telehealth deals are a new way around ...
Eli Lilly (LLY) announced that the Medicines and Healthcare products Regulatory Agency, or MHRA, has granted marketing authorization for ...
Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.
Despite this, investors seem to have made up their one-track mind. Eli Lilly’s P/E ratio is more than double that of Novo ...
The Smithsonian Institution has received $40m from the Lilly Endowment for its upcoming celebrations of the 250th anniversary ...
Eli Lilly’s Alzheimer’s disease offering Kinsunla is poised to face a tough road ahead in the U.K. | Lilly's Alzheimer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback